- Home
- KNOP vs TVGN Comparison
KNOP vs TVGN Comparison
Compare KNOP & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- TVGN
- Stock Information
- Founded
- KNOP 2013
- TVGN 2020
- Country
- KNOP United Kingdom
- TVGN United States
- Employees
- KNOP N/A
- TVGN N/A
- Industry
- KNOP Marine Transportation
- TVGN Blank Checks
- Sector
- KNOP Consumer Discretionary
- TVGN Finance
- Exchange
- KNOP Nasdaq
- TVGN Nasdaq
- Market Cap
- KNOP 187.6M
- TVGN 174.4M
- IPO Year
- KNOP 2013
- TVGN N/A
- Fundamental
- Price
- KNOP $5.62
- TVGN $1.43
- Analyst Decision
- KNOP
- TVGN
- Analyst Count
- KNOP 0
- TVGN 0
- Target Price
- KNOP N/A
- TVGN N/A
- AVG Volume (30 Days)
- KNOP 72.3K
- TVGN 4.9M
- Earning Date
- KNOP 02-24-2025
- TVGN 02-20-2025
- Dividend Yield
- KNOP 1.87%
- TVGN N/A
- EPS Growth
- KNOP N/A
- TVGN N/A
- EPS
- KNOP N/A
- TVGN N/A
- Revenue
- KNOP $299,790,000.00
- TVGN N/A
- Revenue This Year
- KNOP $7.66
- TVGN N/A
- Revenue Next Year
- KNOP $1.75
- TVGN N/A
- P/E Ratio
- KNOP N/A
- TVGN N/A
- Revenue Growth
- KNOP 4.75
- TVGN N/A
- 52 Week Low
- KNOP $4.94
- TVGN $0.26
- 52 Week High
- KNOP $9.11
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- KNOP 44.69
- TVGN 54.34
- Support Level
- KNOP $5.42
- TVGN $1.30
- Resistance Level
- KNOP $5.79
- TVGN $1.54
- Average True Range (ATR)
- KNOP 0.18
- TVGN 0.17
- MACD
- KNOP -0.04
- TVGN 0.01
- Stochastic Oscillator
- KNOP 38.24
- TVGN 35.14
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.